New Mountain will be getting more money back. But this time it’s Ikaria that’s paying out a $172 million dividend.

Venrock will see a return of more than 15x on its investment in SlideShare after just four years, says Brian Ascher, a Venrock partner who sits on the company’s board.

Keynote Systems, a provider of Internet and mobile cloud testing & monitoring, has elected Anthony Sun to its board of directors. Tony Sun was a general partner of Venrock Associates (Rockefeller Family Venture Funds) for over 30 years and managing general partner and CEO for the last eight years, retiring in 2010. In his career, [...]

Celladon Corp., a developer of treatments for cardiovascular diseases, has closed on $43 million in new capital. Pfizer Venture Investments led the round, which included investment from new backers Lundbeckfond Ventures, Novartis Venture Funds, H&Q Healthcare/Life Sciences Investors, and GBS Venture Partners. All previous investors participated in this round, including Enterprise Partners Venture Capital, Johnson [...]

Smartling said it raised a $10 million Series B round of financing from existing investors U.S. Venture Partners, Venrock and First Round Capital, and new investor IDG Ventures. The New York company is developing a cloud-based platform to help Web businesses create and maintain multilingual sites. PRESS RELEASE SMARTLING RAISES $10 MILLION TO MAKE EVERY [...]

Gazelle said Thursday it closed a $22 million series D round of financing led by Craton Equity Partners. The Boston-based e-commerce company’s round received participation from existing investors Physic Ventures, Venrock Associates and RockPort Capital. PRESS RELEASE Gazelle Raises $22 Million Led by Craton Equity Partners Series D Round Primes Gazelle for Continued Industry Leadership [...]

(Reuters) – Zeltiq Aesthetics Inc., a venture-backed company that uses a patented cooling technology to eliminate fat bulges, has filed with U.S. regulators to raise up to $115 million in an initial public offering. The company has raised $104.3 million in venture capital since 2005 from Advanced Technology Ventures (ATV), Aisling Capital, Frazier Healthcare and [...]

Constellation Pharmaceuticals has raised $15 million in an extension to its Series B round, the company announced Monday. Third Rock Ventures, The Column Group, Venrock Associates, SR One and Altitude Life Science Ventures – all existing shareholders – participated in the round. The latest infusion will help Constellation move its products toward clinical development. The company develops small molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders and other diseases.

Acquisitions of venture-backed companies appear to be continuing at a decent pace, with the announcement yesterday that eBay has agreed to buy VC-backed mobile ad startup Where Inc. Given that the purchase price wasn’t disclosed, it’s unclear how Where’s backers will fare on the deal. The Boston-based company raised a total of $16.1 million over [...]